Supply Issues Medicare Plus International Ltd Barrier Cream ELY536 (ICN 3081)

• The supply issue with Barrier Cream with Medicare Plus International is continuing.
• One product remains affected in total:
  • ELY536 – Barrier Cream non sterile 2g.
• The affected product remains subject to intermittent supply.
• Potential indirect alternative products are available to order through our online catalogue:
  • ELY85078 and ELY85159.
• Please note, alternative products ELY85115 and ELY346 are currently suspended and unavailable to order.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is now anticipated to be resolved by 28 November 2025.

• The supply issue with Barrier Cream with Medicare Plus International is continuing.
• One product remains affected:
  • ELY536 – Barrier Cream non sterile 2g.
• The affected product is no longer subject to Protect Demand Management and is now subject to intermittent supply.
• Potential indirect alternative products are available to order through our online catalogue:
  • ELY346, ELY85078, ELY85159 and ELY85115.
• To mitigate disruption customers are advised to order the alternatives provided.
• We are still currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is now anticipated to be resolved by 20 October 2025.

Change:

• The supplier Medicare Plus International Limited has informed us of a supply issue with its Barrier Cream.
• There is one product affected:
  • ELY536 – Barrier Cream non sterile 2g.
• The supply issue is due manufacturing issues.
• Due to this ongoing supply issue this product is now being threshold managed as it is subject to Protect Demand Management.

Impact:

• The affected product is available to order through NHS Supply Chain. However, trusts are allocated a maximum daily quantity or “threshold” to ensure fair supply of available stock across the NHS.
• Potential indirect alternative products are available to order through our online catalogue.
• We are currently sourcing further alternatives and updates will be made to the product listing as soon as possible.
• See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
• The supply issue is anticipated to be resolved by 10 October 2025.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products.
• However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
• We will update the ICN when we have further information.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.

Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.